questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Chimiokines
Chimiokines CXC
Chimiokines CXC : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chimiokines CXC : Questions médicales les plus fréquentes",
"headline": "Chimiokines CXC : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chimiokines CXC : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-09",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chimiokines CXC"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chimiokines",
"url": "https://questionsmedicales.fr/mesh/D018925",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines",
"code": {
"@type": "MedicalCode",
"code": "D018925",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL1",
"alternateName": "Chemokine CXCL1",
"url": "https://questionsmedicales.fr/mesh/D054360",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL1",
"code": {
"@type": "MedicalCode",
"code": "D054360",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL16",
"alternateName": "Chemokine CXCL16",
"url": "https://questionsmedicales.fr/mesh/D000075743",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL16",
"code": {
"@type": "MedicalCode",
"code": "D000075743",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL5",
"alternateName": "Chemokine CXCL5",
"url": "https://questionsmedicales.fr/mesh/D054365",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL5",
"code": {
"@type": "MedicalCode",
"code": "D054365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL6",
"alternateName": "Chemokine CXCL6",
"url": "https://questionsmedicales.fr/mesh/D054427",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL6",
"code": {
"@type": "MedicalCode",
"code": "D054427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL9",
"alternateName": "Chemokine CXCL9",
"url": "https://questionsmedicales.fr/mesh/D054370",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL9",
"code": {
"@type": "MedicalCode",
"code": "D054370",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL10",
"alternateName": "Chemokine CXCL10",
"url": "https://questionsmedicales.fr/mesh/D054357",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL10",
"code": {
"@type": "MedicalCode",
"code": "D054357",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL11",
"alternateName": "Chemokine CXCL11",
"url": "https://questionsmedicales.fr/mesh/D054371",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL11",
"code": {
"@type": "MedicalCode",
"code": "D054371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL12",
"alternateName": "Chemokine CXCL12",
"url": "https://questionsmedicales.fr/mesh/D054377",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL12",
"code": {
"@type": "MedicalCode",
"code": "D054377",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL13",
"alternateName": "Chemokine CXCL13",
"url": "https://questionsmedicales.fr/mesh/D054382",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL13",
"code": {
"@type": "MedicalCode",
"code": "D054382",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-4 plaquettaire",
"alternateName": "Platelet Factor 4",
"url": "https://questionsmedicales.fr/mesh/D010978",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-4 plaquettaire",
"code": {
"@type": "MedicalCode",
"code": "D010978",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines CXC",
"alternateName": "Chemokines, CXC",
"code": {
"@type": "MedicalCode",
"code": "D019743",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Amin Ullah",
"url": "https://questionsmedicales.fr/author/Amin%20Ullah",
"affiliation": {
"@type": "Organization",
"name": "Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Bairong Shen",
"url": "https://questionsmedicales.fr/author/Bairong%20Shen",
"affiliation": {
"@type": "Organization",
"name": "Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Gholamhossein Hassanshahi",
"url": "https://questionsmedicales.fr/author/Gholamhossein%20Hassanshahi",
"affiliation": {
"@type": "Organization",
"name": "Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Dept. of Hematology, Faculty of Biomed, Biomedical Sciences, Kerman University of Medical Sciences, Kerman, Iran."
}
},
{
"@type": "Person",
"name": "Mojgan Noroozi Karimabad",
"url": "https://questionsmedicales.fr/author/Mojgan%20Noroozi%20Karimabad",
"affiliation": {
"@type": "Organization",
"name": "Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: mojgan.noroozi@yahoo.com."
}
},
{
"@type": "Person",
"name": "Tracy M Handel",
"url": "https://questionsmedicales.fr/author/Tracy%20M%20Handel",
"affiliation": {
"@type": "Organization",
"name": "Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Monocytic Subsets Impact Cerebral Cortex and Cognition: Differences Between Healthy Subjects and Patients With First-Episode Schizophrenia.",
"datePublished": "2022-07-11",
"url": "https://questionsmedicales.fr/article/35898501",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.900284"
}
},
{
"@type": "ScholarlyArticle",
"name": "Causality between inflammatory bowel disease and the cerebral cortex: insights from Mendelian randomization and integrated bioinformatics analysis.",
"datePublished": "2023-07-27",
"url": "https://questionsmedicales.fr/article/37588593",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1175873"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rational Design and Acoustic Assembly of Human Cerebral Cortex-Like Microtissues from hiPSC-Derived Neural Progenitors and Neurons.",
"datePublished": "2023-06-29",
"url": "https://questionsmedicales.fr/article/37170683",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/adma.202210631"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cerebral cortex activation and functional connectivity during low-load resistance training with blood flow restriction: An fNIRS study.",
"datePublished": "2024-05-23",
"url": "https://questionsmedicales.fr/article/38781264",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0303983"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuropeptide FF (NPFF)-positive nerve cells of the human cerebral cortex and white matter in controls, selected neurodegenerative diseases, and schizophrenia.",
"datePublished": "2024-06-28",
"url": "https://questionsmedicales.fr/article/38943180",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40478-024-01792-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chimiokines",
"item": "https://questionsmedicales.fr/mesh/D018925"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chimiokines CXC",
"item": "https://questionsmedicales.fr/mesh/D019743"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chimiokines CXC - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chimiokines CXC",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chimiokines CXC",
"description": "Comment diagnostiquer une dysrégulation des chimiokines CXC ?\nQuels tests sont utilisés pour mesurer les chimiokines CXC ?\nLes chimiokines CXC sont-elles liées à des maladies spécifiques ?\nPeut-on détecter les chimiokines CXC dans les biopsies ?\nLes niveaux de chimiokines CXC varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Cerebral+Cortex&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chimiokines CXC",
"description": "Quels symptômes sont associés à une surproduction de chimiokines CXC ?\nLes chimiokines CXC peuvent-elles causer des symptômes respiratoires ?\nComment les chimiokines CXC affectent-elles le système nerveux ?\nLes chimiokines CXC sont-elles liées à des symptômes cutanés ?\nPeut-on observer des symptômes digestifs liés aux chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Cerebral+Cortex&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chimiokines CXC",
"description": "Peut-on prévenir les maladies liées aux chimiokines CXC ?\nL'alimentation influence-t-elle les chimiokines CXC ?\nL'exercice physique affecte-t-il les niveaux de chimiokines CXC ?\nLe tabagisme influence-t-il les chimiokines CXC ?\nLe stress chronique affecte-t-il les chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Cerebral+Cortex&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chimiokines CXC",
"description": "Quels traitements ciblent les chimiokines CXC ?\nLes corticostéroïdes affectent-ils les chimiokines CXC ?\nComment les inhibiteurs de chimiokines CXC fonctionnent-ils ?\nLes traitements anti-inflammatoires influencent-ils les chimiokines CXC ?\nY a-t-il des essais cliniques sur les chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Cerebral+Cortex&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chimiokines CXC",
"description": "Quelles complications peuvent survenir avec des niveaux élevés de chimiokines CXC ?\nLes chimiokines CXC sont-elles impliquées dans le cancer ?\nComment les chimiokines CXC affectent-elles la cicatrisation des plaies ?\nLes maladies cardiovasculaires sont-elles liées aux chimiokines CXC ?\nLes chimiokines CXC peuvent-elles causer des troubles neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Cerebral+Cortex&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chimiokines CXC",
"description": "Quels facteurs de risque augmentent les niveaux de chimiokines CXC ?\nLes infections peuvent-elles influencer les chimiokines CXC ?\nL'exposition à des polluants affecte-t-elle les chimiokines CXC ?\nLe vieillissement influence-t-il les chimiokines CXC ?\nLes maladies métaboliques sont-elles liées aux chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Cerebral+Cortex&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des chimiokines CXC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de cytokines peuvent aider à évaluer les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer les chimiokines CXC ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages ELISA et les tests multiplex sont couramment utilisés pour mesurer les chimiokines."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC sont-elles liées à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent associées à des maladies inflammatoires et auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les chimiokines CXC dans les biopsies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chimiokines peuvent être détectées dans les tissus par immunohistochimie."
}
},
{
"@type": "Question",
"name": "Les niveaux de chimiokines CXC varient-ils selon l'âge ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de chimiokines peuvent varier avec l'âge et l'état de santé général."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une surproduction de chimiokines CXC ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent inflammation, douleur, fatigue et troubles immunitaires."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC peuvent-elles causer des symptômes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont impliquées dans des maladies respiratoires comme l'asthme et la BPCO."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CXC affectent-elles le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent contribuer à des troubles neurologiques en modulant l'inflammation cérébrale."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC sont-elles liées à des symptômes cutanés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être impliquées dans des maladies cutanées inflammatoires comme le psoriasis."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes digestifs liés aux chimiokines CXC ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent jouer un rôle dans des maladies inflammatoires de l'intestin."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux chimiokines CXC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène de vie et la gestion du stress peuvent aider à prévenir certaines maladies."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les chimiokines CXC ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut réduire l'inflammation et les chimiokines."
}
},
{
"@type": "Question",
"name": "L'exercice physique affecte-t-il les niveaux de chimiokines CXC ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler les niveaux de chimiokines et améliorer la santé immunitaire."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les chimiokines CXC ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente les niveaux de chimiokines et contribue à l'inflammation."
}
},
{
"@type": "Question",
"name": "Le stress chronique affecte-t-il les chimiokines CXC ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter l'expression des chimiokines et aggraver l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les chimiokines CXC ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques et des inhibiteurs de chimiokines sont en développement."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils les chimiokines CXC ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'expression des chimiokines CXC dans l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment les inhibiteurs de chimiokines CXC fonctionnent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils bloquent les récepteurs des chimiokines, réduisant ainsi l'inflammation et la migration cellulaire."
}
},
{
"@type": "Question",
"name": "Les traitements anti-inflammatoires influencent-ils les chimiokines CXC ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent moduler les niveaux de chimiokines et améliorer les symptômes inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques sur les chimiokines CXC ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent des traitements ciblant les chimiokines CXC."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des niveaux élevés de chimiokines CXC ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies auto-immunes, des infections chroniques et des cancers."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC sont-elles impliquées dans le cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent favoriser la progression tumorale et la métastase dans certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CXC affectent-elles la cicatrisation des plaies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction peut retarder la cicatrisation en exacerbant l'inflammation."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées aux chimiokines CXC ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de chimiokines sont associés à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC peuvent-elles causer des troubles neurologiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont impliquées dans des troubles comme la sclérose en plaques et l'Alzheimer."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque augmentent les niveaux de chimiokines CXC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et le stress chronique sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles influencer les chimiokines CXC ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections aiguës et chroniques peuvent augmenter l'expression des chimiokines."
}
},
{
"@type": "Question",
"name": "L'exposition à des polluants affecte-t-elle les chimiokines CXC ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des polluants environnementaux peut augmenter les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Le vieillissement influence-t-il les chimiokines CXC ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner une augmentation des niveaux de chimiokines et de l'inflammation."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques sont-elles liées aux chimiokines CXC ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent augmenter les niveaux de chimiokines et l'inflammation."
}
}
]
}
]
}
Monocytes are a highly heterogeneous population subcategorized into classical, intermediate and nonclassical subsets. How monocytes and their subsets may shape brain structures and functions in schizo...
Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is a chronic, progressive, and recurrent intestinal condition that poses a significant global health ...
Leveraging genetic data from genome-wide association studies and Immunochip genotype analyses of nearly 150,000 individuals, we conducted a two-sample Mendelian randomization study to elucidate the dr...
Here, 115, 69, and 98 instrumental variables genetically predicted IBD, UC, and CD. We found that CD significantly decreased the surface area of the temporal pole gyrus (β = -0.946 mm...
We explore the causality between intestinal inflammation and altered cortical morphology. It is likely that neuroinflammation-induced damage, impaired neurological function, and persistent nociceptive...
Development of biologically relevant and clinically relevant human cerebral cortex models is demanded by mechanistic studies of human cerebral cortex-associated neurological diseases and discovery of ...
Despite accumulating evidence that blood flow restriction (BFR) training promotes muscle hypertrophy and strength gain, the underlying neurophysiological mechanisms have rarely been explored. The prim...
We quantified and determined for the first time the distribution pattern of the neuropeptide NPFF in the human cerebral cortex and subjacent white matter. To do so, we studied n = 9 cases without neur...
Amide proton transfer (APT) imaging has shown its diagnostic and predictive superiority in Parkinson's disease (PD) in our previous studies using 2D APT imaging based on deep nuclei. We hypothesized t...
34 patients with idiopathic Parkinson's disease (IPD) and 29 age- and sex-matched normal controls (NC) were enrolled in this prospective study. 3D-APT imaging and 3D-T1WI was performed in our particip...
There wasn't any correlations between cortical APT-related signals and clinical assessment, including the H&Y scale, the disease duration, the UPDRS III scores and the MMSE scores. The MTRasym, CESTRn...
3D-APT imaging could identify the changes of the cerebral cortex in Parkinson's disease. The cortical changes of APT-related parameters could potentially serve as imaging biomarkers to aid in the non-...
Previous studies have confirmed that miR-146a-5p overexpression suppresses neurogenesis, thereby enhancing depression-like behaviors. However, it remains unclear how miR-146a-5p dysregulation produces...
In this case-control study, we combined cortical morphology analysis of magnetic resonance imaging (MRI) and miR-146a-5p quantification to investigate the neuropathological effect of miR-146a-5p on co...
In total, 113 medication-free MDD patients and 107 matched healthy controls were included. Vertex-vise general linear model revealed miR-146a-5p-dependent cortical thinning in MDD patients compared wi...
The findings of this study reveal a relationship between miR-146a-5p overexpression and cortical atrophy and thus may help specify the...
Understanding the laminar brain structure is of great help in further developing our knowledge of the functions of the brain. However, since most layer segmentation methods are invasive, it is difficu...
Pain is known to have sensory and affective components. The sensory pain component is encoded by neurons in the primary somatosensory cortex (S1), whereas the emotional or affective pain experience is...
The transition from normal to chronic pain is believed to involve alterations in several brain areas that participate in the perception of pain. These plastic changes are then responsible for aberrant...